Sort
78,016 grants matching “breast cancer”
CIRCULAR MRNA VACCINE PLATFORM FOR IMMUNOTHERAPY OF BREAST CANCER DORMANCY
$1,112,535Regents Of The University Of Michigan · · FY2022 · Defense Health Agency
Integrated analyses of genetics, epigenetics, and gene expression
$1,112,396Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2023 · CA
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
$1,112,100Bing Li · University Of Iowa · U01 · FY2024 · CA
ROLES OF SYNTHETIC VIABILITY IN BREAST CANCER DEVELOPMENT AND THERAPY
$1,111,845Rutgers, The State University Of New Jersey · · FY2015 · Department of Defense
DREAM: Discovering cancer Risks from Environmental contaminants And Maternal/child health
$1,111,823Peggy Reynolds · University Of California, San Francisco · UG3 · FY2022 · CA
Real-time Multimodal Diffuse Reflectance and Polarization Imaging Based Nerve Identification in Surgical Field of View
$1,111,771Justin Baba · Yaya Scientific, Llc · R42 · FY2024 · EB
Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer
$1,111,562Tillman Gerngross · Dartmouth College · U54 · FY2010 · CA
Tumor Microenvironment Interactions in Brain Tumors
$1,111,508Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2010 · CA
NOVEL MECHANISMS GOVERNING HUMAN BREAST CANCER CHROMOSOMAL INSTABILITY
$1,111,051Baruch S. Blumberg Institute · · FY2018 · Department of the Army
Genetic Epidemiology of Cancer
$1,110,655Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2021 · HG
ADOPTIVE CELL THERAPY AGAINST TRIPLE-NEGATIVE BREAST CANCER USING A NOVEL TMUC1 ANTIBODY-DERIVED CAR
$1,110,546University Of North Carolina At Charlotte · · FY2018 · Defense Health Agency
Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial
$1,110,521Loic Le Marchand · University Of Hawaii At Manoa · R01 · FY2022 · CA
Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial
$1,110,521Loic Le Marchand · University Of Hawaii At Manoa · R01 · FY2023 · CA
TGF-betas in breast cancer progression
$1,110,311Lalage Wakefield · Basic Sciences · Z01 · FY2007 · CA
SCULPTING ANTITUMOR IMMUNITY AS AN APPROACH TO TREAT METASTATIC BREAST CANCER
$1,110,218University Of Alabama At Birmingham · · FY2018 · Defense Health Agency
COBRE FOR SIGNAL TRANSDUCTION AND CANCER PHASE III
$1,110,000Laura F Gibson · West Virginia University · P30 · FY2011 · RR
CoBRE for Signal Transduction and Cancer Phase III
$1,110,000Laura F Gibson · West Virginia University · P30 · FY2015 · GM
CoBRE for Signal Transduction and Cancer Phase III
$1,110,000Laura F Gibson · West Virginia University · P30 · FY2011 · RR
CoBRE for Signal Transduction and Cancer Phase III
$1,110,000Laura F Gibson · West Virginia University · P30 · FY2014 · GM
CoBRE for Signal Transduction and Cancer Phase III
$1,110,000Laura F Gibson · West Virginia University · P30 · FY2012 · GM
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,109,810Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2021 · CA
Advancing Systems Approaches to Personal and Population Breast Cancer Screening
$1,109,727Anna N. A. Tosteson · Dartmouth College · U54 · FY2014 · CA
TARGETING THE SYNTHETIC ESSENTIAL KINASES OF BREAST CANCERS
$1,109,614Duke University · · FY2015 · Department of Defense
Genetic Epidemiology of Lung Cancer
$1,109,255Marshall W Anderson · University Of Cincinnati · U01 · FY2007 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,109,082Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2022 · CA